Shares of Moderna (NASDAQ: MRNA) rose on Tuesday after the biotech provided investors with an update on its COVID-19 vaccine production efforts. As of 1 p.m. EST, Moderna's stock price was up more than 4%.
Moderna has already delivered more than 30 million doses of its coronavirus vaccine to the U.S. government. Roughly 10.1 million of these doses were given to Americans, according to the U.S. Centers for Disease Control and Prevention.
Moderna expects to hit its COVID-19 vaccine production goals. Image source: Getty Images.
Source Fool.com